0000939767-17-000159.txt : 20170928 0000939767-17-000159.hdr.sgml : 20170928 20170928194541 ACCESSION NUMBER: 0000939767-17-000159 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170926 FILED AS OF DATE: 20170928 DATE AS OF CHANGE: 20170928 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schwab Gisela CENTRAL INDEX KEY: 0001213140 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30235 FILM NUMBER: 171108752 MAIL ADDRESS: STREET 1: 6701 KAISER DRIVE CITY: FREMONT STATE: CA ZIP: 94555 FORMER NAME: FORMER CONFORMED NAME: SCHWAB GISELA MD DATE OF NAME CHANGE: 20030107 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: EXELIXIS, INC. CENTRAL INDEX KEY: 0000939767 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 043257395 STATE OF INCORPORATION: DE FISCAL YEAR END: 0102 BUSINESS ADDRESS: STREET 1: 210 E. GRAND AVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6508377000 MAIL ADDRESS: STREET 1: 210 E. GRAND AVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: EXELIXIS INC DATE OF NAME CHANGE: 20000207 FORMER COMPANY: FORMER CONFORMED NAME: EXELIXIS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20000106 4 1 wf-form4_150664232692666.xml FORM 4 X0306 4 2017-09-26 0 0000939767 EXELIXIS, INC. EXEL 0001213140 Schwab Gisela C/O EXELIXIS, INC. 210 E. GRAND AVE. SOUTH SAN FRANCISCO CA 94080 0 1 0 0 Pres Prod Dev & Med Aff & CMO Common Stock 2017-09-26 4 M 0 33333 9.91 A 216338 D Common Stock 2017-09-26 4 S 0 33333 23.68 D 183005 D Common Stock 2017-09-27 4 M 0 33333 9.91 A 216338 D Common Stock 2017-09-27 4 S 0 33333 23.94 D 183005 D Common Stock 2017-09-28 4 M 0 33334 9.91 A 216339 D Common Stock 2017-09-28 4 S 0 33334 23.74 D 183005 D Common Stock 14186 I By 401(k) Option (right to buy) 9.91 2017-09-26 4 M 0 33333 0 D 2008-12-06 2017-12-05 Common Stock 33333.0 66667 D Option (right to buy) 9.91 2017-09-27 4 M 0 33333 0 D 2008-12-06 2017-12-05 Common Stock 33333.0 33334 D Option (right to buy) 9.91 2017-09-28 4 M 0 33334 0 D 2008-12-06 2017-12-05 Common Stock 33334.0 0 D Includes 20,000 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $23.66 to $23.80. Reporting person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4. Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $23.70 to $24.22. Reporting person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4. Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $23.70 to $23.76. Reporting person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 4 to this Form 4. Represents 14,186 shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of September 26, 2017. The option, representing the right to purchase a total of 200,000 shares of Exelixis, Inc. common stock, became fully exercisable on December 6, 2011. /s/ Jeffrey J. Hessekiel, Attorney in Fact 2017-09-28